SEC Filings

SEC Filings

Filing date	Description	Form	View
Nov 29, 2023	Report of unscheduled material events or corporate event	8-K	View HTML 0001558370-23-019380.pdf 0001558370-23-019380.rtf 0001558370-23-019380.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Nov 09, 2023	Report of unscheduled material events or corporate event	8-K	View HTML 0001558370-23-018328.pdf 0001558370-23-018328.rtf 0001558370-23-018328.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Nov 09, 2023	Quarterly report which provides a continuing view of a company's financial position	10-Q	View HTML 0001558370-23-018344.pdf 0001558370-23-018344.rtf 0001558370-23-018344.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Nov 08, 2023	Statement of changes in beneficial ownership of securities	4	View HTML 0001235802-23-000110.pdf 0001235802-23-000110.rtf 0001235802-23-000110.xls
Oct 13, 2023	Report of unscheduled material events or corporate event	8-K	View HTML 0001104659-23-109130.pdf 0001104659-23-109130.rtf 0001104659-23-109130.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Oct 05, 2023	Report of unscheduled material events or corporate event	8-K	View HTML 0001104659-23-107164.pdf 0001104659-23-107164.rtf 0001104659-23-107164.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Oct 03, 2023	Form of prospectus disclosing information facts events covered in both forms 424B1 424B3	424B4	View HTML 0001104659-23-106172.pdf 0001104659-23-106172.rtf 0001104659-23-106172.xls
Sep 29, 2023	EFFECT	EFFECT	View HTML 9999999995-23-002883.pdf 9999999995-23-002883.rtf 9999999995-23-002883.xls
Sep 28, 2023	CORRESP	CORRESP	View HTML 0001104659-23-104570.pdf 0001104659-23-104570.rtf 0001104659-23-104570.xls
Sep 27, 2023	Amended Registration statement for face-amount certificate companies	S-1/A	View HTML 0001104659-23-104363.pdf 0001104659-23-104363.rtf 0001104659-23-104363.xls

Data provided by Kaleidoscope.

For investor inquiries, please contact:

ReShape Lifesciences Investor Contact:
Thomas Stankovich
Chief Financial Officer
949-276-6042
ir@ReShapeLifesci.com

Investor Contacts:
Rx Communications Group
Michael Miller
917-633-6086
mmiller@rxir.com

PRINT PAGE

EMAIL PAGE